Regeneron Pharmaceuticals, Inc.;University Health Network
发明人:
Lisa Arleen Purcell Ngambo,Sarah J. Higgins,Kevin C. Kain
申请号：
US15414925
公开号：
US09968653B2
申请日:
2017.01.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
